Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience

Detalles Bibliográficos
Autores principales: Gangat, Naseema, Oliveira, Jennifer L., Porter, Tavanna R, Hoyer, James D., Al-Kali, Aref, Patnaik, Mrinal M, Pardanani, Animesh, Tefferi, Ayalew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052925/
https://www.ncbi.nlm.nih.gov/pubmed/35142155
http://dx.doi.org/10.3324/haematol.2021.280516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052925/
https://www.ncbi.nlm.nih.gov/pubmed/35142155
http://dx.doi.org/10.3324/haematol.2021.280516

Ejemplares similares